Imvaq Therapeutics
Latest round
- Series B
Last raised
- Sep 2020
Total raised
- $15M
Investors
- 1
About Imvaq Therapeutics
Imvaq Therapeutics Corp.Founded in 2016 and headquartered in New York, US, Imvaq Therapeutics Corp. specializes in transformative therapies for cancer treatment.Imvaq Therapeutics Corp. provides a range of innovative therapeutic solutions specifically designed to address oncology market needs. Their core offerings focus on advanced treatment modalities aimed at enhancing patient outcomes, utilized by healthcare institutions including hospitals and clinical research organizations.Imvaq Therapeutics Corp. generates revenue through direct sales of its therapeutics and by engaging clients through tailored service agreements which ensure ongoing support and updates.Imvaq Therapeutics Corp. The company aims to expand its market reach into Asia and Latin America by 2023, reinforcing its commitment to enhancing cancer treatment accessibility globally.
Who invested in Imvaq Therapeutics
1 investor across 1 round
See all investors in Imvaq Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Sep 28, 2020
Amount
$15M
Investors
Questions about Imvaq Therapeutics
Who invested in Imvaq Therapeutics?
Imvaq Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Imvaq Therapeutics raised?
Imvaq Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Imvaq Therapeutics last raise money?
Imvaq Therapeutics's most recent round on record is a Series B, in Sep 2020.
What does Imvaq Therapeutics do?
Imvaq Therapeutics is a biotechnology company.
Where is Imvaq Therapeutics headquartered?
Imvaq Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Imvaq Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Imvaq Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Imvaq Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.